Matches in SemOpenAlex for { <https://semopenalex.org/work/W1480636761> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1480636761 endingPage "1379" @default.
- W1480636761 startingPage "1375" @default.
- W1480636761 abstract "The aim of the present study was to characterize the excretion of pure vitexin-4”-O-glucoside (VOG) in mice following oral and intravenous administration at a dose of 30 mg/kg. A sensitive and specific HPLC method with hespridin as internal standard, a Diamonsil C18 column protected with a KR C18 guard column and a mixture consisting of methanol–acetonitrile–tetrahydrofuran–0.1% glacial acetic acid (6:2:18:74, v/v/v/v) as mobile phase was developed and validated for quantitative analysis in biological samples. VOG could be excreted as prototype in excreta including urine and feces after both routes of administration, and the cumulative excretion of VOG was 24.31 ± 11.10% (17.97 ± 5.59% in urinary excretion; 6.34 ± 5.51% in fecal excretion) following oral dosing and 5.66 ± 3.94% (4.78 ± 3.13% in urinary excretion; 0.88 ± 0.81% in fecal excretion) following intravenous dosing. The results showed that the elimination of VOG after the two routes was fairly low, which meant that VOG was metabolized as other forms and the elimination after oral dosing was almost 4.3-fold that after intravenous dosing. For both routes of administration, VOG excreted as prototype in urine was much more than that in feces, nearly 2.83-fold for oral administration and 5.43-fold for intravenous administration, which should be attributed to enterohepatic circulation. Taken together, renal excretion was the dominant path of elimination of VOG for oral and intravenous administration in mice and biliary excretion contributed less. Copyright © 2013 John Wiley & Sons, Ltd." @default.
- W1480636761 created "2016-06-24" @default.
- W1480636761 creator A5041737602 @default.
- W1480636761 creator A5042610567 @default.
- W1480636761 creator A5058554865 @default.
- W1480636761 creator A5075403679 @default.
- W1480636761 date "2013-06-13" @default.
- W1480636761 modified "2023-10-18" @default.
- W1480636761 title "Comparative study on the excretion of vitexin-4′′-O-glucoside in mice after oral and intravenous administration by using HPLC" @default.
- W1480636761 cites W1539703972 @default.
- W1480636761 cites W1973058491 @default.
- W1480636761 cites W1988102452 @default.
- W1480636761 cites W2045853111 @default.
- W1480636761 cites W2057972584 @default.
- W1480636761 cites W2088134752 @default.
- W1480636761 cites W2111220012 @default.
- W1480636761 doi "https://doi.org/10.1002/bmc.2931" @default.
- W1480636761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23760836" @default.
- W1480636761 hasPublicationYear "2013" @default.
- W1480636761 type Work @default.
- W1480636761 sameAs 1480636761 @default.
- W1480636761 citedByCount "4" @default.
- W1480636761 countsByYear W14806367612013 @default.
- W1480636761 countsByYear W14806367612020 @default.
- W1480636761 countsByYear W14806367612021 @default.
- W1480636761 crossrefType "journal-article" @default.
- W1480636761 hasAuthorship W1480636761A5041737602 @default.
- W1480636761 hasAuthorship W1480636761A5042610567 @default.
- W1480636761 hasAuthorship W1480636761A5058554865 @default.
- W1480636761 hasAuthorship W1480636761A5075403679 @default.
- W1480636761 hasConcept C10146269 @default.
- W1480636761 hasConcept C178790620 @default.
- W1480636761 hasConcept C179998833 @default.
- W1480636761 hasConcept C185592680 @default.
- W1480636761 hasConcept C2777056448 @default.
- W1480636761 hasConcept C2777288759 @default.
- W1480636761 hasConcept C2778620825 @default.
- W1480636761 hasConcept C2780026642 @default.
- W1480636761 hasConcept C43617362 @default.
- W1480636761 hasConcept C55493867 @default.
- W1480636761 hasConcept C62231903 @default.
- W1480636761 hasConcept C71924100 @default.
- W1480636761 hasConcept C98274493 @default.
- W1480636761 hasConceptScore W1480636761C10146269 @default.
- W1480636761 hasConceptScore W1480636761C178790620 @default.
- W1480636761 hasConceptScore W1480636761C179998833 @default.
- W1480636761 hasConceptScore W1480636761C185592680 @default.
- W1480636761 hasConceptScore W1480636761C2777056448 @default.
- W1480636761 hasConceptScore W1480636761C2777288759 @default.
- W1480636761 hasConceptScore W1480636761C2778620825 @default.
- W1480636761 hasConceptScore W1480636761C2780026642 @default.
- W1480636761 hasConceptScore W1480636761C43617362 @default.
- W1480636761 hasConceptScore W1480636761C55493867 @default.
- W1480636761 hasConceptScore W1480636761C62231903 @default.
- W1480636761 hasConceptScore W1480636761C71924100 @default.
- W1480636761 hasConceptScore W1480636761C98274493 @default.
- W1480636761 hasIssue "11" @default.
- W1480636761 hasLocation W14806367611 @default.
- W1480636761 hasLocation W14806367612 @default.
- W1480636761 hasOpenAccess W1480636761 @default.
- W1480636761 hasPrimaryLocation W14806367611 @default.
- W1480636761 hasRelatedWork W118183763 @default.
- W1480636761 hasRelatedWork W1970888742 @default.
- W1480636761 hasRelatedWork W2008587079 @default.
- W1480636761 hasRelatedWork W2008727242 @default.
- W1480636761 hasRelatedWork W2012905376 @default.
- W1480636761 hasRelatedWork W2035747744 @default.
- W1480636761 hasRelatedWork W2061879738 @default.
- W1480636761 hasRelatedWork W2315828595 @default.
- W1480636761 hasRelatedWork W2321818949 @default.
- W1480636761 hasRelatedWork W2322692385 @default.
- W1480636761 hasVolume "27" @default.
- W1480636761 isParatext "false" @default.
- W1480636761 isRetracted "false" @default.
- W1480636761 magId "1480636761" @default.
- W1480636761 workType "article" @default.